Treatment Outcomes
Generic DAAs achieve excellent cure rates in Egypt matching those of branded drugs at a fraction of the cost
Michael Carter / 01 February 2019
Generic direct-acting antivirals (DAAs) are just as effective and safe as their branded equivalents for the treatment of chronic hepatitis C virus (HCV) infection, according to Egyptian research published in Liver International. Generics achieved...
Read more: http://www.infohep.org/page/3426337/
Updates
On This Blog
Controversy and barriers over hepatitis C drugs
Link to news articles addressing barriers to hepatitis C treatment, for instance insurance restrictions of these therapies by private insurers Medicare or Medicaid. In addition review research articles on the effectiveness, safety and availability of generic versions of hepatitis C medications.
Link to news articles addressing barriers to hepatitis C treatment, for instance insurance restrictions of these therapies by private insurers Medicare or Medicaid. In addition review research articles on the effectiveness, safety and availability of generic versions of hepatitis C medications.
No comments:
Post a Comment